chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Healthy, no symptoms prior to vaccination. Vaccinated at mass temporary clinic approx. 3PM.  Symptoms appeared within 24 hours.  Coughing, phlegm, headache, chills and fever.  Persist until this report (12-26-04).  Suspect that flu vaccine was rushed to meet emergency, and contained live virus.  Christmas ruined. Would like to know if others vaccinated in this mass operation were also affected.  We will never get vaccinated again without determining the identity of the personnel, or the details of the vaccine (lot number, manufacturer, etc.) - an expensive lesson that "free" treatment can be costly.  My husband and I usually get our flu shots in a hospital at a small charge and have never experienced this.
I was very sick for basically 5 days.  Muscle pain, lethargic, profusely sweating, headache, upset stomach.  I know all 'normal' side effects of the vaccine.   What scared me was that I woke up on Sunday morning (1/8) and both of my legs were tingling (a beginning symptom of Guillain -Barre syndrome.  AND the left hand side of my face was numb!  Both gone by days end.
3/26/2021 received 1st shot in left arm @11:45am  -That night sore arm and very sleepy at 8pm.  Took Tylenol and went to sleep  3/27/2021 woke about 8am with a massive headache, sensitivity to light and noise, eyes burning, alternating between chills and sweating with low grade fever 96.9  3/28/2021 headache still persistent, burning eyes, upset stomach, alternating between chills and Sweaty.
Felt Flushed about 15 minutes after receiving vaccine. Within 30 minutes of receiving vaccine states she feels "itchy around my eyes" Benadryl 25mg po administered. At 12:35PM, 50 minutes after receiving vaccine hives appear on her rt shoulder, opposite arm from vaccination. 12:40 PM 2nd 25 mg Benadryl po administered. PCP called pt to continue with Benadryl 50 mg 3x day prn and prescription for prednisone. To receive seasonal influenza vaccine with PCP or allergist in the future.
This spontaneous report as received from a female physician of unknown age refers to herself. "About one week ago", on approximately 25-SEP-2014 the patient was vaccinated with ZOSTAVAX (strength and dose was not reported), lot # K003601, expiration date: 19-MAR-2015), administered subcutaneously in the tricep area of the upper arm rather than the deltoid region by the pharmacist. No adverse effects reported. Additional information has been requested.
Within about 5-7 minutes post the injection, I started getting a headache and mild nausea.  I was monitored in the ER because I have had known severe drug reactions.  I took some Tylenol and had some ice chips.  I was light sensitive.  I ended up leaving work early that day due to the headache worsening, light sensitivity and nausea.  I had a horrible migraine that same day by the time I got home, unable to tolerate any light, skull sore to the touch, felt like brain was about to explode.  I had increasing nausea. I took more Tylenol(can't take ibuprofen due to kidney and bladder disease).  I also had to take Zofran for the nausea. I had to keep all lights off and stay in the bed for three days.  I developed a fever of 101 degrees by 8pm, it increased to 103.5 degrees by 9-10pm, still with severe migraine and nausea.  Nothing  relieved the headache.  I continued with the migraine and nausea on day two.  Fever did not subside until the afternoon on day 3.  I did not get relief from the headache until the evening on day 3.
This is a spontaneous report from a contactable consumer or other non hcp (Patient herself). A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 22Mar2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced horrible reaction where her throat closed up, unable to swallow on Mar2021. The consumer said that she was vaccinated in on 22Mar2021 and had an immediate and horrible reaction where her throat closed up and was unable to swallow. She also said that she was almost hospitalized. The outcome of the event was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Day after vaccine noted leg swelling down to knee. Resolved by 5-16-17 and no cellulitis noted.
Painful right foot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful right foot) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Painful right foot). At the time of the report, PAIN IN EXTREMITY (Painful right foot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was unknown by the reporter. Treatment information was not provided.
Very nauseous, dizzy, confused, the WORSE gas I have ever had in my life - sorry! Lol - on day 4 of symptoms now
Patient  became very pale, limp, diaphoretic, had rapid shallow breathing, and would respond by nodding but did not speak (child normally speaks), about 15-20 minutes after the vaccine was given. Patient was laid down, feet were elevated, he drank juice and over the next 15-20 minutes symptoms slowly resolved. Vitals were taken and returned to normal.
Racing heart / Now has to take heart meds; This is a spontaneous report from a contactable consumer, the patient. A 15-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in right arm on an unknown date as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On an unknown date, the patient experienced racing heart, he then had to take heart medications. The event resulted in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event and included treatment with heart medications. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event racing heart was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow-up.
Seizures after, dr visit, waiting to see neurologist, smell sensation, shaking, dizziness, migraine, vision issue, bowl movement. From seconds to 1-3 minutes.
Pt had unprovoked pulmonary embolism 3 weeks after booster vaccine with pfizer.; third dose; Also received flu vaccine on the same date; Also received flu vaccine on the same date; This is a spontaneous report from a contactable Physician. A 61-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 3 via an unspecified route of administration on 20Oct2021 (Batch/Lot number was not reported) at the age of 61-years-old as single dose for covid-19 immunisation; influenza vaccine (INFLUENZA), via an unspecified route of administration on 20Oct2021 (Batch/Lot number was not reported) at single dose for immunization. Medical history included type 2 diabetes mellitus. No Covid prior vaccination. No known allergies. The patient's concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 01Mar2021 (Batch/Lot number was not reported) at the age of 60-years-old; dose 2 via an unspecified route of administration on 01May2021 (Batch/Lot number was not reported) at the age of 61-years-old for covid-19 immunisation. On 09Nov2021, patient had unprovoked pulmonary embolism 3 weeks after booster vaccine with Pfizer. Also received flu vaccine on the same date. The event resulted in hospitalization for one day. The patient received treatment: anticoagulation for the event. Outcome of the event pulmonary embolism was recovered with sequel.  The lot number for BNT162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 vaccine can not be excluded for the reported events of Immunisation and Pulmonary embolism. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Information has been received from a physician via medical records concerning an 16 day old female patient who on 23-APR-2008 was vaccinated with first dose of Hepatitis B vaccine (manufacturer unknown). On approximately 08-SEP-2008 the baby had some constipation, well child care PRN was suggested. On 30-Oct-2008 the patient was vaccinated with a second dose of Hepatitis B vaccine (manufacturer unknown). Concomitant therapy included a dose of (CRM197) PREVNAR and a dose of PENTACEL. On 01-JAN-2009 the patient experienced congested. On 05-JAN-2009 the patient was taken to visit the physician and was diagnosed with upper respiratory tract infection which persisted at that time. At the same date, the baby was vaccinated with a dose of PENTACEL, PREVENAR. Additional information has been requested.
fever, irritability, dec appetite 10 days p/vax;rhinorrhea & lt OM on exam;
Patient received MENACTRA on 11/9/12 left arm. On 11/10/12 pt. developed "whelps", hives, very itchy, hives on both arms and legs. Pt. used BENADRYL. On 11/11/12 early AM< pt. went to ER. Given BENADRYL 50mg q 8 hours, MEDROL DOSE PACK, PEPCID.
COVID 19; SUSPECTED CLINICAL VACCINATION FAILURE; VASCULAR ISSUES; HEART ISSUES; This spontaneous report received from a patient via a company representative via social media concerned multiple patients with unspecified age, sex, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (Janssen series 1) (suspension for injection, route of admin, batch number: unknown and expiry date: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the reporter stated that, "personally know people who took the jabs, got covid and some have died". The reporter also stated that, "have very recently lost vaxxed friends who died from covid and I have had people I know who have heart and vascular issue since getting the jab".  On an unspecified date, the patient had suspected clinical vaccination failure. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of covid 19 and the outcome of vascular issues, heart issues and suspected clinical vaccination failure was not reported. This report was serious (Death, and Other Medically Important Condition). This report was associated with product quality complaint: 90000206905. This case, from the same reporter is linked to 20211230784.; Sender's Comments: V0: 20211230489-covid-19 vaccine ad26.cov2.s -Covid 19 . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211230489-covid-19 vaccine ad26.cov2.s- suspected clinical vaccination failure . This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS; Reported Cause(s) of Death: COVID 19 INFECTION
It appears the patient was given a bivalent booster dose less than 2 months after their last monovalent booster dose.
Positive Covid-19 Test on 4/5/21 with symptoms after vaccination on 3/23/21
Administration error: while administering bivalent vaccine, needle was not good and vaccine came out; Administration error: while administering bivalent vaccine, needle was not good and vaccine came out; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Administration error: while administering bivalent vaccine, needle was not good and vaccine came out), NEEDLE ISSUE (Administration error: while administering bivalent vaccine, needle was not good and vaccine came out) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Administration error: while administering bivalent vaccine, needle was not good and vaccine came out), NEEDLE ISSUE (Administration error: while administering bivalent vaccine, needle was not good and vaccine came out) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Administration error: while administering bivalent vaccine, needle was not good and vaccine came out), NEEDLE ISSUE (Administration error: while administering bivalent vaccine, needle was not good and vaccine came out) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for ACCIDENTAL UNDERDOSE (Administration error: while administering bivalent vaccine, needle was not good and vaccine came out) and NEEDLE ISSUE (Administration error: while administering bivalent vaccine, needle was not good and vaccine came out).    Concomitant medications were not reported. No treatment information was provided by the reporter.   Reporter did not allow further contact
INFLAMMATION; FLU LIKE SYMPTOMS; FEELS LIKE NOT BALANCED EVERY ONCE IN A WHILE; HEADACHE (BECOMES WORSE  LIKE A MIGRAINE); NAUSEA/FEEL LIKE I WANT TO THROW UP; FATIGUE COMES AND GOES; INJECTION SITE PAIN; THREW UP 2 OR 3 TIMES; TINGLING OF THE WHOLE FOOT/LEFT FINGERS/RIGHT FINGERS; FEELING EVERY THING IS HEAVY FOR THE FEET; This spontaneous report received from a patient concerned a 36 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: seasonal allergies, and other pre-existing medical conditions included: Patient had no medical conditions. The patient was previously treated with loratadine for seasonal allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 07-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On SEP-2021, the patient experienced feeling every thing is heavy for the feet. On SEP-2021, the patient experienced tingling of the whole foot/left fingers/right fingers. On an unspecified date, the patient experienced inflammation, flu like symptoms, feels like not balanced every once in a while, headache (becomes worse like a migraine), nausea/feel like i want to throw up, fatigue comes and goes, injection site pain, and threw up 2 or 3 times. Laboratory data (dates unspecified) included: Blood test NOS (NR: not provided) Normal, COVID-19 rapid POC test (NR: not provided) Negative, Negative, CT scan (NR: not provided) results awaiting, Normal, Chest scan (NR: not provided) Normal, Electrocardiogram (NR: not provided) Normal, and SARS-CoV-2 RT-PCR test (NR: not provided) Negative. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms, and injection site pain, and feeling every thing is heavy for the feet on SEP-2021, had not recovered from headache (becomes worse like a migraine), nausea/feel like i want to throw up, fatigue comes and goes, tingling of the whole foot/left fingers/right fingers, inflammation, and threw up 2 or 3 times, and the outcome of feels like not balanced every once in a while was not reported. This report was non-serious.
Severe headache, slight fever/chills, joint aches, nausea for 36 hours
The pt received MMR SQ on left arm at approximately 11am. Approximately five mins later the pt experienced pain axillary area adjacent to injection site. Pain scale from a-10 was five with constant area of pain under the arm. Applied ice.
Client was fully vaccinated for covid-19, date of death 08/07/2021, cause of death complicatons of covid-19
Given the Flu vaccine in the early PM of 10/31/2001. By 7:30 PM that evening pt states she had severe chills and a fever about 103. Severe flu symptoms. Still ill on 11/1/2001 chills and fever. Back to work 11/02/2001, feeling better. Did not go to MD.
Fatigue, muscle pain, skin sensitivity, chills, nausea, high fevers (headache?, joint pain? - don?t recall)
Several seconds after the first dose the patient stopped talking, had tremors in hands and feet and slumped to the right.  Developed cold sweat, pupils dilatated and was non-responsive but breathing normally (not labored and steady).  911 was contacted immediately and the patient began to speak very weakly but could not respond in full words or sentences and remained very weak, she maintained an open airway and was placed on the floor to aid in perfusion to her brain, the paramedics arrived in roughly 5 minutes and transported her to the Hospital. No history of any seizures/panic episodes etc reported by mother.
patients received the vaccine pass 30 days in the fridge/The vaccine was received frozen from the health department and place in the fridge at proper temperature; Patients received the vaccine pass 30 days in the fridge; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received the vaccine pass 30 days in the fridge) and PRODUCT STORAGE ERROR (patients received the vaccine pass 30 days in the fridge/The vaccine was received frozen from the health department and place in the fridge at proper temperature) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002M21A) for COVID-19 vaccination.     No Medical History information was reported.    In 2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received the vaccine pass 30 days in the fridge). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (patients received the vaccine pass 30 days in the fridge/The vaccine was received frozen from the health department and place in the fridge at proper temperature). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received the vaccine pass 30 days in the fridge) and PRODUCT STORAGE ERROR (patients received the vaccine pass 30 days in the fridge/The vaccine was received frozen from the health department and place in the fridge at proper temperature) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patients was elderly Patients was not immunocompromised. All patients taking medication. Patients received their 2nd booster of the vaccine. No patients reported having side effects. Some patients allergic to penicillin and sulfa. One was allergic to statin drugs like Lipitor.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-615211, US-MODERNATX, INC.-MOD-2022-615212, US-MODERNATX, INC.-MOD-2022-615213 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-615211:patient 2- elderly female 2 US-MODERNATX, INC.-MOD-2022-615212:patient 3- elderly male 1 US-MODERNATX, INC.-MOD-2022-615213:patient 4- elderly male 2
going to get a COVID test today; sore arm; headache; cannot taste my foods/ Sweet and salty especially./it seems to be just affecting my taste; This case was reported by a consumer and described the occurrence of suspected covid-19 in a patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included viral infection, taste loss and loss of smell (Viral infection).   On 3rd June 2021, the patient received the 1st dose of Shingrix. On 4th June 2021, 1 days after receiving Shingrix, the patient experienced suspected covid-19, pain in arm, headache and taste loss. On an unknown date, the outcome of the suspected covid-19, pain in arm, headache and taste loss were unknown.   It was unknown if the reporter considered the suspected covid-19, pain in arm, headache and taste loss to be related to Shingrix.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The patient received 1st dose of Shingrix vaccine and experienced common side effects of headache, sore arm and also discovered that could not taste foods sweet and salty especially.  The patient had previously lost his/her taste and smell with a viral infection October 2019, prior to COVID but this was improving and at this point it was limited to wine tasting bad. The patient Smells and tastes were both affected at that time and right now it seems to be just affecting taste. The patient was vaccinated fully for COVID, but going to get a COVID test today. The patient wanted to know this is related to the vaccine or not. The reporter consent to follow up.
Swelling of lymph nodes under right arm.  About the size of a golf ball just below arm pit.
Patient reported that appearance of a "pimple" on his arn after vaccination at site of vaccination. Patient was afraid it might be an infection and scheduled an appointment with MD. Also reported pain, redness and swelling.